Trinity Biotech ADR buy StockNews.com
Start price
26.02.23
/
50%
€0.99
Target price
26.02.24
-
Performance (%)
-56.95%
End price
27.02.24
-
Summary
This prediction is currently being closed. The BUY prediction by StockNews_com for Trinity Biotech ADR is performing very badly with a performance of -56.95%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Trinity Biotech ADR | - | - | - | - |
| iShares Core DAX® | -1,86 % | -1,62 % | 0,64 % | 51,03 % |
| iShares Nasdaq 100 | -3,32 % | 3,32 % | 32,00 % | 86,51 % |
| iShares Nikkei 225® | -2,30 % | 3,44 % | 51,01 % | 58,81 % |
| iShares S&P 500 | -1,31 % | 2,44 % | 23,01 % | 65,41 % |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten